{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:13:25Z","timestamp":1791209605802,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.ejpb.2011.11.017","type":"journal-article","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T19:05:54Z","timestamp":1323284754000},"page":"544-552","source":"Crossref","is-referenced-by-count":34,"title":["In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease"],"prefix":"10.1016","volume":"80","author":[{"given":"M.","family":"Rodriguez-Aller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Guillarme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Stella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Furrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rudaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"El Zaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Valamanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Di Tommaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Behar-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-L.","family":"Veuthey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gurny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2011.11.017_b0005","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ajo.2008.05.016","article-title":"Advances in understanding and managing dry eye disease","volume":"146","author":"Lemp","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2011.11.017_b0010","first-page":"S79","article-title":"Dry eye disease: pathophysiology, classification, and diagnosis","volume":"14","author":"Perry","year":"2008","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.ejpb.2011.11.017_b0015","first-page":"57","article-title":"The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca","volume":"3","author":"Gumus","year":"2009","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ejpb.2011.11.017_b0020","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.preteyeres.2004.04.003","article-title":"Changes in the tear film and ocular surface from dry eye syndrome","volume":"23","author":"Johnson","year":"2004","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejpb.2011.11.017_b0025","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0161-6420(03)00462-7","article-title":"Utility assessment among patients with dry eye disease","volume":"110","author":"Schiffman","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2011.11.017_b0030","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0939-6411(03)00138-3","article-title":"Cyclosporine A delivery to the eye: a pharmaceutical challenge","volume":"56","author":"Lallemand","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2011.11.017_b0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/14740338.7.1.79","article-title":"Uses and safety profile of ciclosporin in opthalmology","volume":"7","author":"Kashani","year":"2008","journal-title":"Expert Opin. Grug Saf."},{"key":"10.1016\/j.ejpb.2011.11.017_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399400001769","article-title":"Molecular targets for existing and novel immunosuppressive drugs","volume":"2","author":"Stepkowski","year":"2000","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.ejpb.2011.11.017_b0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","article-title":"Mechanisms of action of cyclosporine","volume":"47","author":"Matsuda","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.ejpb.2011.11.017_b0050","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.mehy.2004.03.030","article-title":"Molecular effects of cyclosporine and oncogenesis: a new model","volume":"63","author":"Andre","year":"2004","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ejpb.2011.11.017_b0055","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1006\/exer.1998.0619","article-title":"Cyclosporin A increases tear fluid secretion via release of sensory neurotransmitters and muscarinic pathway in mice","volume":"68","author":"Yoshida","year":"1999","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejpb.2011.11.017_b0060","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0021-5155(98)00003-3","article-title":"Effect of cyclosporin A eyedrops on tear secretion in rabbit","volume":"42","author":"Toshida","year":"1998","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2011.11.017_b0065","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/0002-9343(84)90356-5","article-title":"Side effects of systemic cyclosporine in patients not undergoing transplantation","volume":"77","author":"Palestine","year":"1984","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejpb.2011.11.017_b0070","series-title":"Clarke\u2019s Isolation and Identification of Drugs","author":"Clarke","year":"1986"},{"key":"10.1016\/j.ejpb.2011.11.017_b0075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1399-3011.2003.00111.x","article-title":"Cyclosporin A prodrugs: design, synthesis and biophysical properties","volume":"63","author":"Hamel","year":"2004","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.ejpb.2011.11.017_b0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejpb.2004.07.002","article-title":"Conversion of cyclosporine A prodrugs in human tears vs. rabbits tears","volume":"59","author":"Lallemand","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2011.11.017_b0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijpharm.2004.12.015","article-title":"A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics","volume":"295","author":"Lallemand","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.11.017_b0090","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejps.2005.05.003","article-title":"A water-soluble prodrug of cyclosporine A for ocular application: a stability study","volume":"26","author":"Lallemand","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2011.11.017_b0095","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ejpb.2007.03.011","article-title":"Biological conversion of a water-soluble prodrug of cyclosporine A","volume":"67","author":"Lallemand","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2011.11.017_b0100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0378-5173(00)00540-8","article-title":"Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants","volume":"207","author":"Furrer","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.11.017_b0105","series-title":"Applied Biopharmaceutics & Pharmacokinetics","author":"Shargel","year":"2005"},{"key":"10.1016\/j.ejpb.2011.11.017_b0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejpb.2009.09.002","article-title":"Recent advances in confocal microscopy for studying drug delivery to the eye: concepts and pharmaceutical applications","volume":"74","author":"Furrer","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2011.11.017_b0115","unstructured":"P. K\u00e4lin, Contribution \u00e0 la validation d\u2019un test de tol\u00e9rance oculaire sur la souris, in, University of Lausanne, Lausanne, 1994."},{"key":"10.1016\/j.ejpb.2011.11.017_b0120","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00003226-198404000-00008","article-title":"Cyclosporin A on human corneal endothelium","volume":"3","author":"Singh","year":"1984","journal-title":"Cornea"},{"key":"10.1016\/j.ejpb.2011.11.017_b0125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2008.08.004","article-title":"Novel microemulsion in situ electrolyte-triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: in vitro and in vivo results","volume":"365","author":"Gan","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.11.017_b0130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2165\/00003088-200544030-00003","article-title":"Ocular pharmacokinetics and safety of ciclosporin, a novel topical treatment for dry eye","volume":"44","author":"Tang-Liu","year":"2005","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejpb.2011.11.017_b0135","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","article-title":"Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The cyclosporin A phase 2 study group","volume":"107","author":"Stevenson","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2011.11.017_b0140","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1208\/ps040102","article-title":"Ocular tolerance of absorption enhancers in ophthalmic preparations","volume":"4","author":"Furrer","year":"2002","journal-title":"AAPS PharmSci"},{"key":"10.1016\/j.ejpb.2011.11.017_b0145","series-title":"Ocular Therapeutics and Drug Delivery: A Multidisciplinary Approach","first-page":"489","article-title":"Evaluation of primary ocular irritation: alternative to the Draize test","author":"Hutak","year":"1996"},{"key":"10.1016\/j.ejpb.2011.11.017_b0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.aca.2009.10.004","article-title":"A review of current trends and advances in modern bio-analytical methods: chromatography and sample preparation","volume":"656","author":"Novakova","year":"2009","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ejpb.2011.11.017_b0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.trac.2009.09.008","article-title":"Coupling ultra-high-pressure liquid chromatography with mass spectrometry","volume":"29","author":"Guillarme","year":"2010","journal-title":"Trac-Trends Anal. Chem."},{"key":"10.1016\/j.ejpb.2011.11.017_b0160","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000078776","article-title":"Lachrymal determinations: methods and updates on biopharmaceutical and clinical applications","volume":"36","author":"Dumortier","year":"2004","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.ejpb.2011.11.017_b0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cca.2005.12.035","article-title":"Laboratory findings in tear fluid analysis","volume":"369","author":"Ohashi","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejpb.2011.11.017_b0170","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1167\/iovs.03-1055","article-title":"Animal models of dry eye: a critical assessment of opportunities and limitations","volume":"45","author":"Barabino","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2011.11.017_b0175","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0939-6411(97)00064-7","article-title":"Ocular pharmacokinetics\/pharmacodynamics","volume":"44","author":"Worakul","year":"1997","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2011.11.017_b0180","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/archopht.1990.01070060132063","article-title":"Ocular penetration of cyclosporine A in the rat eye","volume":"108","author":"BenEzra","year":"1990","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ejpb.2011.11.017_b0185","first-page":"650","article-title":"Intraocular penetration of topically applied cyclosporine","volume":"20","author":"Kaswan","year":"1988","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejpb.2011.11.017_b0190","unstructured":"C. Di Tommaso, F. Valamenesh, F. Miller, P. Furrer, M. Rodriguez-Aller, F. Behar-Cohen, R. Gurny, M. Moller, A novel cyclosporin A aqueous formulation for dry eye treatment: in vitro and in vivo evaluation, submitted for publication."},{"key":"10.1016\/j.ejpb.2011.11.017_b0195","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2011.11.017_b0200","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/bjo.74.6.350","article-title":"Ocular penetration of cyclosporin A. III: The human eye","volume":"74","author":"BenEzra","year":"1990","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2011.11.017_b0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1076\/ceyr.18.2.91.5381","article-title":"Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs","volume":"18","author":"Acheampong","year":"1999","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejpb.2011.11.017_b0210","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1442-9071.2008.01784.x","article-title":"Topical cyclosporin A in the treatment of acute graft rejection: a randomized controlled trial","volume":"36","author":"Poon","year":"2008","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ejpb.2011.11.017_b0215","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.addr.2006.07.024","article-title":"Drug transport in corneal epithelium and blood\u2013retina barrier: emerging role of transporters in ocular pharmacokinetics","volume":"58","author":"Mannermaa","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2011.11.017_b0220","first-page":"1362","article-title":"Ocular penetration of cyclosporin A. The rabbit eye","volume":"31","author":"BenEzra","year":"1990","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2011.11.017_b0225","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/108076802317233243","article-title":"Distribution of cyclosporin A in the cornea after topical or oral administration","volume":"18","author":"Theng","year":"2002","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2011.11.017_b0230","first-page":"519","article-title":"Pharmacokinetic of topical cyclosporin A in the rabbit eye","volume":"27","author":"Wiederholt","year":"1986","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2011.11.017_b0235","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1023\/A:1013671819604","article-title":"Cyclosporine A formulation affects its ocular distribution in rabbits","volume":"19","author":"Kuwano","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2011.11.017_b0240","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease, CsA phase 3 study group","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2011.11.017_b0245","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00003226-199307000-00007","article-title":"Pilot trial of cyclosporine 1% ophthalmic ointment in the treatment of keratoconjunctivitis sicca","volume":"12","author":"Laibovitz","year":"1993","journal-title":"Cornea"},{"key":"10.1016\/j.ejpb.2011.11.017_b0250","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9394(14)77061-8","article-title":"Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis","volume":"110","author":"Secchi","year":"1990","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2011.11.017_b0255","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0161-6420(89)32756-4","article-title":"Topical cyclosporine in high-risk corneal transplants","volume":"96","author":"Belin","year":"1989","journal-title":"Ophthalmology"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641111003353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641111003353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T09:41:28Z","timestamp":1713174088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641111003353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0939641111003353"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2011.11.017","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}